Home/Pipeline/Cerebro Platform for Epilepsy

Cerebro Platform for Epilepsy

Epilepsy

Pre-clinicalActive

Key Facts

Indication

Epilepsy

Phase

Pre-clinical

Status

Active

Company

Vonova.io

About Vonova.io

Vonova is pioneering a transvascular platform to revolutionize brain access by using the venous system, thereby avoiding the risks and invasiveness of traditional craniotomy. Founded in 2020 and based in San Francisco, the company's 'Cerebro Platform' is a guided neurovascular system designed to improve recovery times and expand treatment options for millions of patients with chronic neurological disorders. Having secured seed financing and recognition as a MedTech Innovator finalist, Vonova is positioned at the intersection of neuroscience and advanced device technology to address a significant unmet clinical need.

View full company profile

Therapeutic Areas

Chronic Subdural Hematoma Neuropathic Pain Epilepsy

Other Epilepsy Drugs

Drug	Company	Phase	Status
ADX71149 (mGlu2 PAM)	Addex Therapeutics	Phase 2	Active (with Janssen)
TRV045	Trevena	Phase 1	Active
SAGE-324	Sage Therapeutics	Preclinical	Research
Motpoly XR™	Aucta Pharmaceuticals	Not Specified (Likely Phase 3/NDA)	Active
ADB-104	Adolore BioTherapeutics	Pre-clinical	Active
Not Publicly Disclosed	Cerecin	Phase 2	Active
eTNS Platform	NeuroSigma	Unknown	Active
NPT 2042	NeuroPro Therapeutics	Phase 2	Active
Spritam (levetiracetam)	Aprecia Pharmaceuticals	Approved	Active
Perampanel	Ark Diagnostics	In Development	Active
NeuroAccess Platform	Cordance Medical	Pre-clinical/Research	Active
Epilepsy Program	Current Surgical	Research	Active